JPMORGAN CHASE & CO - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$191,756
-34.4%
147,505
-18.2%
0.00%
Q2 2023$292,243
-38.3%
180,397
-19.0%
0.00%
Q1 2023$474,000
+6771328.6%
222,576
+12279.1%
0.00%
Q4 2022$7
-99.8%
1,798
-62.8%
0.00%
Q3 2022$4,000
-99.5%
4,831
-99.5%
0.00%
Q2 2022$750,000
-15.3%
964,714
-1.3%
0.00%
Q1 2022$885,000
-84.4%
977,794
+37.8%
0.00%
-100.0%
Q4 2021$5,683,000
-28.6%
709,479
-25.4%
0.00%0.0%
Q3 2021$7,960,000
+16.1%
951,060
-6.5%
0.00%0.0%
Q2 2021$6,856,000
+17.1%
1,017,286
+14.9%
0.00%0.0%
Q1 2021$5,853,000
+130.3%
885,555
+46.3%
0.00%
Q4 2020$2,541,000
+64.5%
605,177
+88.8%
0.00%
Q3 2020$1,545,000
+0.7%
320,572
+27.0%
0.00%
Q2 2020$1,535,000
+100.7%
252,431
+81.2%
0.00%
Q1 2020$765,000
+51.5%
139,318
+173.1%
0.00%
Q4 2019$505,000
+8316.7%
51,014
+7676.5%
0.00%
Q2 2019$6,000
-96.6%
656
-94.9%
0.00%
Q1 2019$177,000
+71.8%
12,775
-61.8%
0.00%
Q1 2018$103,000
+505.9%
33,425
+519.0%
0.00%
Q4 2017$17,0000.0%5,400
+52.0%
0.00%
Q4 2016$17,000
-78.8%
3,553
-70.5%
0.00%
Q3 2016$80,000
+175.9%
12,038
+100.0%
0.00%
Q2 2016$29,000
+163.6%
6,019
+160.0%
0.00%
Q1 2016$11,0002,3150.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q2 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders